ICARES Medicus, Inc. (TPEX:6612)
Taiwan · Delayed Price · Currency is TWD 69.80
+1.50 (2.20%)
Jul 30, 2026, 1:30 PM CST
ICARES Medicus Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,233 | 3,502 | 5,278 | 4,934 | 2,774 | 2,337 | |
Market Cap Growth | -34.24% | -33.66% | 6.98% | 77.87% | 18.70% | 11.21% |
Enterprise Value | 3,525 | 3,761 | 5,440 | 4,633 | 2,403 | 2,093 |
Last Close Price | 68.30 | 73.90 | 112.41 | 103.72 | 65.47 | 55.17 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 76.86 | 68.35 | 51.19 | 50.49 | 21.52 | 39.88 |
Forward PE | - | 26.82 | 26.82 | 26.82 | 26.82 | 26.82 |
PS Ratio | 2.86 | 3.10 | 6.14 | 8.15 | 5.42 | 5.93 |
PB Ratio | 1.62 | 1.78 | 2.99 | 2.96 | 2.96 | 2.85 |
P/TBV Ratio | 3.11 | 3.49 | 7.00 | 3.38 | 3.64 | 3.98 |
P/FCF Ratio | - | - | - | - | 28.46 | 70.43 |
P/OCF Ratio | 193.72 | - | - | - | 21.52 | 60.60 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.11 | 3.33 | 6.33 | 7.65 | 4.69 | 5.31 |
EV/EBITDA Ratio | 13.35 | 15.97 | 30.20 | 35.83 | 16.84 | 19.58 |
EV/EBIT Ratio | 31.20 | 29.25 | 44.14 | 42.68 | 19.27 | 23.82 |
EV/FCF Ratio | - | - | - | - | 24.65 | 63.07 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.45 | 0.47 | 0.53 | 0.09 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 3.35 | 3.38 | 4.46 | 0.95 | 0.04 | 0.15 |
Debt / FCF Ratio | - | - | - | - | 0.06 | 0.53 |
Net Debt / Equity Ratio | 0.09 | 0.07 | 0.11 | -0.49 | -0.45 | -0.43 |
Net Debt / EBITDA Ratio | 0.75 | 0.60 | 1.05 | -6.38 | -2.95 | -3.33 |
Net Debt / FCF Ratio | -5.01 | -1.29 | -0.96 | 8.53 | -4.32 | -10.73 |
Asset Turnover | 0.36 | 0.37 | 0.35 | 0.41 | 0.51 | 0.43 |
Inventory Turnover | 1.13 | 1.21 | 1.11 | 1.18 | 1.37 | 1.32 |
Quick Ratio | 1.37 | 1.39 | 1.75 | 9.07 | 6.01 | 4.00 |
Current Ratio | 2.07 | 2.04 | 2.46 | 10.45 | 7.11 | 4.81 |
Return on Equity (ROE) | -0.53% | 0.17% | 3.18% | 4.94% | 12.55% | 4.91% |
Return on Assets (ROA) | 2.28% | 2.60% | 3.13% | 4.60% | 7.76% | 6.05% |
Return on Invested Capital (ROIC) | -1.03% | 0.29% | 2.92% | 9.08% | 19.60% | 9.87% |
Return on Capital Employed (ROCE) | 4.90% | 5.50% | 5.10% | 6.10% | 13.10% | 10.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.31% | 1.46% | 1.95% | 1.98% | 4.65% | 2.51% |
FCF Yield | -1.06% | -3.09% | -3.74% | -1.96% | 3.51% | 1.42% |
Dividend Yield | 0.43% | 0.41% | 0.27% | 0.16% | 1.26% | 0.75% |
Payout Ratio | 30.61% | 25.22% | 7.60% | 34.96% | 13.18% | 5.80% |
Buyback Yield / Dilution | -0.56% | -0.03% | -11.53% | -2.91% | -0.74% | -0.38% |
Total Shareholder Return | -0.13% | 0.37% | -11.26% | -2.75% | 0.53% | 0.36% |